Early deficits in an in vitro striatal microcircuit model carrying the Parkinson's GBA-N370S mutation.
Do QB. et al, (2024), NPJ Parkinsons Dis, 10
Single-cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging, and disease.
Kilfeather P. et al, (2024), Cell Rep, 43
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease models.
Williamson MG. et al, (2023), Hum Mol Genet, 32, 2808 - 2821
Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson's iPSC-dopamine neurons.
Beccano-Kelly DA. et al, (2023), iScience, 26
Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.
Bogetofte H. et al, (2023), Cell Rep, 42
Differentiation of human Dopamine Neurons (DaNs) from induced pluripotent stem cells (iPSCs) v1
ML Cramb K. et al, (2023)
Tau-dependent HDAC1 nuclear reduction is associated with altered VGluT1 expression.
Siano G. et al, (2023), Front Cell Dev Biol, 11
Gene Expression of Disease-related Genes in Alzheimer's Disease is Impaired by Tau Aggregation.
Siano G. et al, (2020), J Mol Biol, 432
What we can learn from iPSC-derived cellular models of Parkinson's disease.
Caiazza MC. et al, (2020), 252, 3 - 25
Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Siano G. et al, (2019), Journal of Visualized Experiments
Identification of an ERK Inhibitor as a Therapeutic Drug Against Tau Aggregation in a New Cell-Based Assay
Siano G. et al, (2019), Frontiers in Cellular Neuroscience, 13
Tau Modulates VGluT1 Expression
Siano G. et al, (2019), Journal of Molecular Biology, 431, 873 - 884